Creatine CEST MRI for Differentiating Gliomas with Different Degrees of Aggressiveness

PurposeCreatine (Cr) is a major metabolite in the bioenergetic system. Measurement of Cr using conventional MR spectroscopy (MRS) suffers from low spatial resolution and relatively long acquisition times. Creatine chemical exchange saturation transfer (CrCEST) magnetic resonance imaging (MRI) is an emerging molecular imaging method for tissue Cr measurements. Our previous study showed that the CrCEST contrast, obtained through multicomponent Z-spectral fitting, was lower in tumors compared to normal brain, which further reduced with tumor progression. The current study was aimed to investigate if CrCEST MRI can also be useful for differentiating gliomas with different degrees of aggressiveness.ProceduresIntracranial 9L gliosarcoma and F98 glioma bearing rats with matched tumor size were scanned with a 9.4 T MRI scanner at two time points. CEST Z-spectra were collected using a customized sequence with a frequency-selective rectangular saturation pulse (B1 = 50 Hz, duration = 3 s) followed by a single-shot readout. Z spectral data were fitted pixel-wise with five Lorentzian functions, and maps of CrCEST peak amplitude, linewidth, and integral were produced. For comparison, single-voxel proton MR spectroscopy (1H-MRS) was performed to quantify and compare the total Cr concentration in the tumor.ResultsCrCEST contrasts decreased with tumor progression from weeks 3 to 4 in both 9L and F98 phenotypes. More importantly, F98 tumors had significantly lower CrCEST integral compared to 9L tumors. On the other hand, integrals of other Z-spectral components were unable to differentiate both tumor progression and phenotype with limited sample size.ConclusionsGiven that F98 is a more aggressive tumor than 9L, this study suggests that CrCEST MRI may help differentiate gliomas with different aggressiveness.

[1]  G. Allison,et al.  The relationship between EMG median frequency and low frequency band amplitude changes at different levels of muscle capacity. , 2002, Clinical biomechanics.

[2]  Rolf F. Barth,et al.  Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas , 2009, Journal of Neuro-Oncology.

[3]  Mark F. Lythgoe,et al.  In vivo imaging of glucose uptake and metabolism in tumors , 2012, Nature Medicine.

[4]  Ravinder Reddy,et al.  CEST signal at 2 ppm (CEST@2ppm) from Z‐spectral fitting correlates with creatine distribution in brain tumor , 2014, NMR in biomedicine.

[5]  S. Forsén,et al.  Study of Moderately Rapid Chemical Exchange Reactions by Means of Nuclear Magnetic Double Resonance , 1963 .

[6]  Ravinder Reddy,et al.  A technique for in vivo mapping of myocardial creatine kinase metabolism , 2014, Nature Medicine.

[7]  Christopher Nimsky,et al.  Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. , 2006, Radiology.

[8]  S. Patra,et al.  Progressive decrease of phosphocreatine, creatine and creatine kinase in skeletal muscle upon transformation to sarcoma , 2008, The FEBS journal.

[9]  S. Bluml,et al.  Efficacy of Proton Magnetic Resonance Spectroscopy Inclinical Decision Making for Patients with Suspected Malignant Brain Tumors , 2004, Journal of Neuro-Oncology.

[10]  L D Lunsford,et al.  Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. , 1993, Journal of neurosurgery.

[11]  C. Claussen,et al.  Brain tumors: MR imaging with gadolinium-DTPA. , 1985, Radiology.

[12]  Bleyer Wa.  Epidemiologic impact of children with brain tumors. , 1999 .

[13]  C. Parker,et al.  Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume. , 2013, The British journal of radiology.

[14]  K. Hess,et al.  Correlation between dynamic MRI and outcome in patients with malignant gliomas , 1998, Neurology.

[15]  M. Wyss,et al.  Elevated creatine kinase activity in primary hepatocellular carcinoma , 2005, BMC gastroenterology.

[16]  Ravinder Reddy,et al.  In vivo chemical exchange saturation transfer imaging of creatine (CrCEST) in skeletal muscle at 3T , 2014, Journal of magnetic resonance imaging : JMRI.

[17]  Ravinder Reddy,et al.  On B1 inhomogeneity correction of in vivo human brain glutamate chemical exchange saturation transfer contrast at 7T , 2013, Magnetic resonance in medicine.

[18]  R. Tanaka,et al.  Magnetic resonance imaging and histopathology of cerebral gliomas , 2004, Neuroradiology.

[19]  R. Gruetter,et al.  In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time , 1999, Magnetic resonance in medicine.

[20]  Tao Jin,et al.  MR imaging of the amide‐proton transfer effect and the pH‐insensitive nuclear overhauser effect at 9.4 T , 2013, Magnetic resonance in medicine.

[21]  Kimberly L Desmond,et al.  Mapping of amide, amine, and aliphatic peaks in the CEST spectra of murine xenografts at 7 T , 2014, Magnetic resonance in medicine.

[22]  E. Shoubridge,et al.  Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading , 1990, NMR in biomedicine.

[23]  R. Kauppinen,et al.  Choline‐Containing Compounds in Human Astrocytomas Studied by 1H NMR Spectroscopy In Vivo and In Vitro , 1994, Journal of neurochemistry.

[24]  M. Bárány,et al.  1H NMR of intact muscle at 11 T , 1984, FEBS letters.

[25]  Thomas Benner,et al.  Investigation of optimizing and translating pH‐sensitive pulsed‐chemical exchange saturation transfer (CEST) imaging to a 3T clinical scanner , 2008, Magnetic resonance in medicine.

[26]  D. Graveron-Demilly,et al.  Java-based graphical user interface for the MRUI quantitation package , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.

[27]  M. Lerner,et al.  Glioma morphology and tumor‐induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography , 2010, Journal of magnetic resonance imaging : JMRI.

[28]  G. Barker,et al.  Precise estimate of fundamental in-vivo MT parameters in human brain in clinically feasible times. , 2002, Magnetic resonance imaging.

[29]  John A. Detre,et al.  Magnetic Resonance Imaging of Glutamate , 2011, Nature Medicine.

[30]  E F Halpern,et al.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.

[31]  J. Frahm,et al.  Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. , 1989, Radiology.

[32]  Stephen Pickup,et al.  Diffusion tensor MRI in rat models of invasive and well‐demarcated brain tumors , 2008, NMR in biomedicine.

[33]  Ravinder Reddy,et al.  Chemical Exchange Saturation Transfer (CEST) Imaging: Description of Technique and Potential Clinical Applications , 2013, Current Radiology Reports.

[34]  Tao Jin,et al.  Magnetic resonance imaging of the Amine–Proton EXchange (APEX) dependent contrast , 2012, NeuroImage.

[35]  G. Marius Clore,et al.  Automated error-tolerant macromolecular structure determination from multidimensional nuclear Overhauser enhancement spectra and chemical shift assignments: improved robustness and performance of the PASD algorithm , 2008, Journal of biomolecular NMR.

[36]  P. Narayana,et al.  Serial proton magnetic resonance spectroscopy of ischemic brain injury in humans. , 1990, Investigative radiology.

[37]  Nirbhay N. Yadav,et al.  Chemical exchange saturation transfer (CEST): What is in a name and what isn't? , 2011, Magnetic resonance in medicine.

[38]  S. Patra,et al.  A short review on creatine–creatine kinase system in relation to cancer and some experimental results on creatine as adjuvant in cancer therapy , 2011, Amino Acids.

[39]  Robert S. Balaban,et al.  NMR imaging of labile proton exchange , 1990 .

[40]  S. Tsung.  Creatine kinase activity and isoenzyme pattern in various normal tissues and neoplasms. , 1983, Clinical chemistry.

[41]  Gil Navon,et al.  Assessment of glycosaminoglycan concentration in vivo by chemical exchange-dependent saturation transfer (gagCEST) , 2008, Proceedings of the National Academy of Sciences.

[42]  S. Rose,et al.  Image directed proton spectroscopy of gerbil brain at 7 Tesla , 1995, NMR in biomedicine.

[43]  Ravinder Reddy,et al.  In vivo mapping of brain myo-inositol , 2011, NeuroImage.

[44]  Ravinder Reddy,et al.  Breast Cancer Redox Heterogeneity Detectable with Chemical Exchange Saturation Transfer (CEST) MRI , 2014, Molecular Imaging and Biology.

[45]  Q. Lu,et al.  T2* relaxation time in the detection and assessment of aggressiveness of peripheral zone cancer in comparison with diffusion-weighted imaging. , 2016, Clinical radiology.

[46]  T. Hanihara,et al.  Creatine kinase isoenzyme BB increased in serum and tumor tissue of patients with giant cell tumor of bone. , 1994, Clinical chemistry.

[47]  H. Brem,et al.  Combination of Intracranial Temozolomide With Intracranial Carmustine Improves Survival When Compared With Either Treatment Alone in a Rodent Glioma Model , 2010, Neurosurgery.

[48]  Ravinder Reddy,et al.  MICEST: A potential tool for non-invasive detection of molecular changes in Alzheimer's disease , 2013, Journal of Neuroscience Methods.

[49]  A. Sapin,et al.  Characterization and detection of experimental rat gliomas using magnetic resonance imaging , 2004, Magnetic Resonance Materials in Physics, Biology and Medicine.

[50]  T. Onda,et al.  Ubiquitous mitochondrial creatine kinase downregulated in oral squamous cell carcinoma , 2006, British Journal of Cancer.

[51]  E. Walker,et al.  Magnetic resonance imaging of benign soft tissue neoplasms in adults. , 2011, Radiologic clinics of North America.

[52]  J. Carreras,et al.  Creatine kinase activity and isoenzymes in lung, colon and liver carcinomas. , 1997, British Journal of Cancer.

[53]  Ravinder Reddy,et al.  Exchange rates of creatine kinase metabolites: feasibility of imaging creatine by chemical exchange saturation transfer MRI , 2012, NMR in biomedicine.

[54]  Jinyuan Zhou,et al.  Amide proton transfer imaging of the human brain. , 2011, Methods in molecular biology.

[55]  Jinyuan Zhou,et al.  Chemical exchange saturation transfer imaging and spectroscopy , 2006 .

[56]  Ravinder Reddy,et al.  Mapping glutamate in subcortical brain structures using high‐resolution GluCEST MRI , 2013, NMR in biomedicine.

[57]  High Resolution Mapping of Modafinil Induced Changes in Glutamate Level in Rat Brain , 2014, PloS one.

[58]  R. de Beer,et al.  Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals , 2001, Comput. Biol. Medicine.

[59]  R S Balaban,et al.  A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). , 2000, Journal of magnetic resonance.

[60]  Peter C M van Zijl,et al.  MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST) , 2007, Proceedings of the National Academy of Sciences.

[61]  A. Bleyer,et al.  Epidemiologic impact of children with brain tumors , 1999, Child's Nervous System.

[62]  David G. Gadian,et al.  Proton MR Spectroscopy of Intracranial Tumours: In Vivo and In Vitro Studies , 1990, Journal of computer assisted tomography.

[63]  Ravinder Reddy,et al.  Characterizing prostate tumor mouse xenografts with CEST and MT-MRI and redox scanning. , 2013, Advances in experimental medicine and biology.

[64]  G. Fuller,et al.  The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. , 1998, Surgical neurology.

[65]  P. V. van Zijl,et al.  Proton NMR spectroscopy of solvent‐saturable resonances: A new approach to study pH effects in Situ , 1998, Magnetic resonance in medicine.

[66]  Peter Bachert,et al.  Inverse Z‐spectrum analysis for spillover‐, MT‐, and T1‐corrected steady‐state pulsed CEST‐MRI – application to pH‐weighted MRI of acute stroke , 2014, NMR in biomedicine.

[67]  M. Thelen,et al.  Tissue characterization with T1, T2, and proton density values: results in 160 patients with brain tumors. , 1988, Radiology.

[68]  A. Panigrahy,et al.  Neuroimaging of Pediatric Brain Tumors: From Basic to Advanced Magnetic Resonance Imaging (MRI) , 2009, Journal of child neurology.

[69]  Jinyuan Zhou,et al.  Amide proton transfer (APT) contrast for imaging of brain tumors , 2003, Magnetic resonance in medicine.

[70]  D. Jenden,et al.  Localized In Vivo 1H Magnetic Resonance Spectroscopy and In Vitro Analyses of Heterogeneous Brain Tumors , 1995, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[71]  Ravinder Reddy,et al.  Imaging of glutamate neurotransmitter alterations in Alzheimer's disease , 2013, NMR in biomedicine.

[72]  T. P. Pretlow,et al.  Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasia. , 1982, Cancer research.

[73]  Ravinder Reddy,et al.  Method for high‐resolution imaging of creatine in vivo using chemical exchange saturation transfer , 2014, Magnetic resonance in medicine.

[74]  C R Bird,et al.  Gliomas: classification with MR imaging. , 1990, Radiology.

[75]  A Dean Sherry,et al.  Chemical exchange saturation transfer contrast agents for magnetic resonance imaging. , 2008, Annual review of biomedical engineering.

[76]  E. Martin,et al.  In vivo detection of GABA and glutamate with MEGA‐PRESS: Reproducibility and gender effects , 2011, Journal of magnetic resonance imaging : JMRI.

[77]  G. Sutherland,et al.  High‐Resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms , 1992, Magnetic resonance in medicine.

[78]  Glyn Johnson,et al.  Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. , 2003, AJNR. American journal of neuroradiology.

[79]  Jin-Suh Kim,et al.  Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. , 2002, AJR. American journal of roentgenology.